# reload+after+2024-01-20 20:43:53.403164
address1§505 Coast Boulevard South
address2§Suite 202
city§La Jolla
state§CA
zip§92037
country§United States
phone§858-952-5500
website§https://www.calcimedica.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
fullTimeEmployees§14
companyOfficers§[{'maxAge': 1, 'name': 'Dr. A. Rachel Leheny Ph.D.', 'age': 60, 'title': 'CEO & Director', 'yearBorn': 1963, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eric W. Roberts', 'age': 59, 'title': 'Chief Business Officer & Vice Chairman of the Board', 'yearBorn': 1964, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael J. Dunn MBA', 'age': 67, 'title': 'President & COO', 'yearBorn': 1956, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Anjana  Rao Ph.D.', 'title': 'Co-Founder and Scientific Advisor', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Patrick  Hogan Ph.D.', 'title': 'Co-Founder and Scientific Advisor', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Stefan  Feske M.D.', 'title': 'Co-Founder and Scientific Advisor', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kenneth A. Stauderman Ph.D.', 'age': 70, 'title': 'Co-Founder & Chief Scientific Officer', 'yearBorn': 1953, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Daniel E. Geffken M.B.A.', 'age': 66, 'title': 'Interim Chief Financial Officer', 'yearBorn': 1957, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Cindy  Reiedenberg', 'title': 'Accountant', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John M. Dunn J.D.', 'age': 71, 'title': 'General Counsel', 'yearBorn': 1952, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§8
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§9
governanceEpochDate§1704067200
maxAge§86400
priceHint§4
payoutRatio§0.0
currency§USD
dateShortInterest§1702598400
forwardEps§-3.5
exchange§NCM
quoteType§EQUITY
shortName§CalciMedica, Inc.
longName§CalciMedica, Inc.
firstTradeDateEpochUtc§1686749400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§1dade7b1-4e24-37e4-9b8f-e0dde73c0e11
gmtOffSetMilliseconds§-18000000
targetHighPrice§14.0
targetLowPrice§6.25
targetMeanPrice§10.13
targetMedianPrice§10.13
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§2
quickRatio§3.958
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
